Literature DB >> 25462659

Contingency management improves smoking cessation treatment outcomes among highly impulsive adolescent smokers relative to cognitive behavioral therapy.

Meghan E Morean1, Grace Kong2, Deepa R Camenga3, Dana A Cavallo2, Kathleen M Carroll4, Brian Pittman2, Suchitra Krishnan-Sarin2.   

Abstract

BACKGROUND: Impulsive adolescents have difficulty quitting smoking. We examined if treatments that provide behavioral incentives for abstinence improve treatment outcomes among impulsive adolescent smokers, who have been shown to be highly sensitive to reward.
METHODS: We ran secondary data analyses on 64 teen smokers (mean age=16.36 [1.44]; cigarettes/day=13.97 [6.61]; 53.1% female; 90.6% Caucasian) who completed a four-week smoking cessation trial to determine whether impulsive adolescents differentially benefit from receiving cognitive behavioral therapy (CBT), contingency management (CM), or the combination of the two (CM/CBT). Indices of treatment efficacy included self-report percent days abstinent and end of treatment biochemically-confirmed 7-day point prevalence abstinence (EOT abstinence). We assessed self-reported impulsivity using the Brief Barratt Impulsiveness Scale. We used univariate Generalized Linear Modeling to examine main effects and interactions of impulsivity and treatment condition as predictors of self-reported abstinence, and exact logistic regression to examine EOT abstinence.
RESULTS: CM/CBT and CM were comparably effective in promoting abstinence, so analyses were conducted comparing the efficacy of CBT to treatments with a CM component (i.e., CM and CM/CBT). CBT and deficient self-regulation predicted lower self-reported abstinence rates within the total analytic sample. Treatments containing CM were more effective than CBT in predicting 1) self-reported abstinence among behaviorally impulsive adolescents (% days abstinent: CM 77%; CM/CBT 81%; CBT 30%) and 2) EOT point prevalence abstinence among behaviorally impulsive adolescents and adolescents with significant deficits in self-regulation.
CONCLUSION: CM-based interventions may improve the low smoking cessation rates previously observed among impulsive adolescent smokers.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Adolescent; Cognitive behavioral therapy; Contingency management; Impulsivity; Smoking cessation

Mesh:

Year:  2014        PMID: 25462659      PMCID: PMC4285343          DOI: 10.1016/j.addbeh.2014.11.009

Source DB:  PubMed          Journal:  Addict Behav        ISSN: 0306-4603            Impact factor:   3.913


  18 in total

1.  Contingency management interventions for treating the substance abuse of adolescents: a feasibility study.

Authors:  E A Corby; J M Roll; D M Ledgerwood; C R Schuster
Journal:  Exp Clin Psychopharmacol       Date:  2000-08       Impact factor: 3.157

2.  Behavioral impulsivity predicts treatment outcome in a smoking cessation program for adolescent smokers.

Authors:  Suchitra Krishnan-Sarin; Brady Reynolds; Amy M Duhig; Anne Smith; Thomas Liss; Amanda McFetridge; Dana A Cavallo; Kathleen M Carroll; Marc N Potenza
Journal:  Drug Alcohol Depend       Date:  2006-10-17       Impact factor: 4.492

Review 3.  Contingency management for treatment of substance use disorders: a meta-analysis.

Authors:  Michael Prendergast; Deborah Podus; John Finney; Lisa Greenwell; John Roll
Journal:  Addiction       Date:  2006-11       Impact factor: 6.526

4.  Assessing the feasibility of using contingency management to modify cigarette smoking by adolescents.

Authors:  John M Roll
Journal:  J Appl Behav Anal       Date:  2005

5.  Smoking cessation treatment for adolescents.

Authors:  Julie P Karpinski; Erin M Timpe; Lisa Lubsch
Journal:  J Pediatr Pharmacol Ther       Date:  2010-10

6.  Contingency management for smoking cessation in adolescent smokers.

Authors:  Suchitra Krishnan-Sarin; Amy M Duhig; Sherry A McKee; Thomas J McMahon; Thomas Liss; Amanda McFetridge; Dana A Cavallo
Journal:  Exp Clin Psychopharmacol       Date:  2006-08       Impact factor: 3.157

7.  Psychometrically improved, abbreviated versions of three classic measures of impulsivity and self-control.

Authors:  Meghan E Morean; Kelly S DeMartini; Robert F Leeman; Godfrey D Pearlson; Alan Anticevic; Suchitra Krishnan-Sarin; John H Krystal; Stephanie S O'Malley
Journal:  Psychol Assess       Date:  2014-06-02

8.  New tricks for an old measure: the development of the Barratt Impulsiveness Scale-Brief (BIS-Brief).

Authors:  Lynne Steinberg; Carla Sharp; Matthew S Stanford; Andra Teten Tharp
Journal:  Psychol Assess       Date:  2012-11-12

9.  An exploratory randomized controlled trial of a novel high-school-based smoking cessation intervention for adolescent smokers using abstinence-contingent incentives and cognitive behavioral therapy.

Authors:  Suchitra Krishnan-Sarin; Dana A Cavallo; Judith L Cooney; Ty S Schepis; Grace Kong; Thomas B Liss; Amanda K Liss; Thomas J McMahon; Charla Nich; Theresa Babuscio; Bruce J Rounsaville; Kathleen M Carroll
Journal:  Drug Alcohol Depend       Date:  2013-03-22       Impact factor: 4.492

10.  Personality differences associated with smoking experimentation among adolescents with and without comorbid symptoms of ADHD.

Authors:  Kenneth P Tercyak; Janet Audrain-McGovern
Journal:  Subst Use Misuse       Date:  2003-12       Impact factor: 2.164

View more
  18 in total

1.  Dimensions of impulsive behavior: Predicting contingency management treatment outcomes for adolescent smokers.

Authors:  Arit M Harvanko; Justin C Strickland; Stacey A Slone; Brent J Shelton; Brady A Reynolds
Journal:  Addict Behav       Date:  2018-11-23       Impact factor: 3.913

2.  The potential impact of cannabis legalization on the development of cannabis use disorders.

Authors:  Alan J Budney; Jacob T Borodovsky
Journal:  Prev Med       Date:  2017-06-28       Impact factor: 4.018

3.  Strategies to promote smoking cessation among adolescents.

Authors:  Johanne Harvey; Nicholas Chadi
Journal:  Paediatr Child Health       Date:  2016-05       Impact factor: 2.253

4.  Impulsivity and approach tendencies towards cigarette stimuli: Implications for cigarette smoking and cessation behaviors among youth.

Authors:  Hanna Weckler; Grace Kong; Helle Larsen; Janna Cousijn; Reinout W Wiers; Suchitra Krishnan-Sarin
Journal:  Exp Clin Psychopharmacol       Date:  2017-10       Impact factor: 3.157

5.  Intra-individual changes in Stroop-related activations linked to cigarette abstinence in adolescent tobacco smokers: Preliminary findings.

Authors:  Sarah W Yip; Iris M Balodis; Kathleen M Carroll; Suchitra Krishnan-Sarin; Marc N Potenza
Journal:  Drug Alcohol Depend       Date:  2016-08-21       Impact factor: 4.492

6.  A feasibility study of home-based contingency management with adolescent smokers of rural Appalachia.

Authors:  Brady Reynolds; Millie Harris; Stacey A Slone; Brent J Shelton; Jesse Dallery; William Stoops; Russell Lewis
Journal:  Exp Clin Psychopharmacol       Date:  2015-08-17       Impact factor: 3.157

Review 7.  Advances in Research on Contingency Management for Adolescent Substance Use.

Authors:  Catherine Stanger; Amy Hughes Lansing; Alan J Budney
Journal:  Child Adolesc Psychiatr Clin N Am       Date:  2016-10

Review 8.  White matter development and tobacco smoking in young adults: A systematic review with recommendations for future research.

Authors:  Alex R Gogliettino; Marc N Potenza; Sarah W Yip
Journal:  Drug Alcohol Depend       Date:  2016-02-27       Impact factor: 4.492

9.  Early age of e-cigarette use onset mediates the association between impulsivity and e-cigarette use frequency in youth.

Authors:  Krysten W Bold; Meghan E Morean; Grace Kong; Patricia Simon; Deepa R Camenga; Dana A Cavallo; Suchitra Krishnan-Sarin
Journal:  Drug Alcohol Depend       Date:  2017-10-13       Impact factor: 4.492

Review 10.  The neurobiology of impulsivity and substance use disorders: implications for treatment.

Authors:  Karolina Kozak; Aliya M Lucatch; Darby J E Lowe; Iris M Balodis; James MacKillop; Tony P George
Journal:  Ann N Y Acad Sci       Date:  2018-10-05       Impact factor: 5.691

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.